Singer Josef, Testori Christoph, Schellongowski Peter, Handisurya Ammon, Müller Catharina, Reitter Eva-Maria, Graninger Wolfgang, Knöbl Paul, Staudinger Thomas, Winkler Stefan, Thalhammer Florian
Division of Infectious Diseases and Tropical Medicine, Department of Internal Medicine I, Medical University of Vienna, 1090, Vienna, Austria.
Department of Emergency Medicine, Medical University of Vienna, 1090, Vienna, Austria.
BMC Infect Dis. 2017 Jun 22;17(1):442. doi: 10.1186/s12879-017-2481-y.
We report a case of septic shock syndrome caused by Streptococcus pneumoniae in a patient who had undergone splenectomy due to an autoimmune lymphoproliferative syndrome (ALPS), which is characterized as a dysfunction of immunoregulation. Although the patient was vaccinated with a conjugated polysaccharide vaccine after the splenectomy, he was still susceptible to S. pneumoniae infection, because the isolated serovar (24F), a serovar long thought to be apathogenic, is not covered by any vaccine currently approved, neither a conjugated nor an unconjugated polysaccharide one.
This case demonstrates that, due to presence of different serovars, also infections with bacteria against which patients are vaccinated have to be considered as differential diagnosis. Although vaccine development has extended the coverage of S. pneumoniae from 7 to 23 serovars within recent years, there is still demand for novel vaccines which can provide broader protection also against so-thought "apathogenic" strains, especially for groups at high risk.
我们报告一例因肺炎链球菌导致的感染性休克综合征病例,患者因自身免疫性淋巴细胞增生综合征(ALPS)接受了脾切除术,该综合征的特征为免疫调节功能障碍。尽管患者在脾切除术后接种了结合多糖疫苗,但他仍易感染肺炎链球菌,因为分离出的血清型(24F),一种长期以来被认为无致病性的血清型,目前任何获批的疫苗,无论是结合疫苗还是非结合多糖疫苗,均未涵盖。
该病例表明,由于存在不同血清型,即使是患者接种过疫苗的细菌感染也必须考虑作为鉴别诊断。尽管近年来疫苗研发已将肺炎链球菌的覆盖血清型从7种扩展至23种,但仍需要新型疫苗,以提供更广泛的保护,抵御那些被认为“无致病性”的菌株,尤其是针对高危人群。